98 related articles for article (PubMed ID: 10395177)
1. Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines.
Yamaguchi K; Okami K; Hibi K; Wehage SL; Jen J; Sidransky D
Cancer Lett; 1999 May; 139(2):183-7. PubMed ID: 10395177
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.
Gemma A; Seike M; Seike Y; Uematsu K; Hibino S; Kurimoto F; Yoshimura A; Shibuya M; Harris CC; Kudoh S
Genes Chromosomes Cancer; 2000 Nov; 29(3):213-8. PubMed ID: 10992296
[TBL] [Abstract][Full Text] [Related]
3. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines.
Myrie KA; Percy MJ; Azim JN; Neeley CK; Petty EM
Cancer Lett; 2000 May; 152(2):193-9. PubMed ID: 10773412
[TBL] [Abstract][Full Text] [Related]
4. Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers.
Imai Y; Shiratori Y; Kato N; Inoue T; Omata M
Jpn J Cancer Res; 1999 Aug; 90(8):837-40. PubMed ID: 10543255
[TBL] [Abstract][Full Text] [Related]
5. hBUB1 defects in leukemia and lymphoma cells.
Ru HY; Chen RL; Lu WC; Chen JH
Oncogene; 2002 Jul; 21(30):4673-9. PubMed ID: 12096343
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of hBUB1, human mitotic checkpoint gene in multiple carcinomas.
Mimori K; Inoue H; Alder H; Ueo H; Tanaka Y; Mori M
Oncol Rep; 2001; 8(1):39-42. PubMed ID: 11115566
[TBL] [Abstract][Full Text] [Related]
7. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer.
Hernando E; Orlow I; Liberal V; Nohales G; Benezra R; Cordon-Cardo C
Int J Cancer; 2001 Jul; 95(4):223-7. PubMed ID: 11400114
[TBL] [Abstract][Full Text] [Related]
8. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer.
Sato M; Sekido Y; Horio Y; Takahashi M; Saito H; Minna JD; Shimokata K; Hasegawa Y
Jpn J Cancer Res; 2000 May; 91(5):504-9. PubMed ID: 10835495
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma.
Ohshima K; Haraoka S; Yoshioka S; Hamasaki M; Fujiki T; Suzumiya J; Kawasaki C; Kanda M; Kikuchi M
Cancer Lett; 2000 Oct; 158(2):141-50. PubMed ID: 10960763
[TBL] [Abstract][Full Text] [Related]
10. Human Bub1: a putative spindle checkpoint kinase closely linked to cell proliferation.
Ouyang B; Lan Z; Meadows J; Pan H; Fukasawa K; Li W; Dai W
Cell Growth Differ; 1998 Oct; 9(10):877-85. PubMed ID: 9790499
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of hBUB1, hBUBR1 and hBUB3 genes in glioblastomas.
Reis RM; Nakamura M; Masuoka J; Watanabe T; Colella S; Yonekawa Y; Kleihues P; Ohgaki H
Acta Neuropathol; 2001 Apr; 101(4):297-304. PubMed ID: 11355300
[TBL] [Abstract][Full Text] [Related]
12. Mutations of mitotic checkpoint genes in human cancers.
Cahill DP; Lengauer C; Yu J; Riggins GJ; Willson JK; Markowitz SD; Kinzler KW; Vogelstein B
Nature; 1998 Mar; 392(6673):300-3. PubMed ID: 9521327
[TBL] [Abstract][Full Text] [Related]
13. Expression of hBUB1 in acute myeloid leukemia.
Lin SF; Lin PM; Yang MC; Liu TC; Chang JG; Sue YC; Chen TP
Leuk Lymphoma; 2002 Feb; 43(2):385-91. PubMed ID: 11999574
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer.
Mondal G; Sengupta S; Panda CK; Gollin SM; Saunders WS; Roychoudhury S
Carcinogenesis; 2007 Jan; 28(1):81-92. PubMed ID: 16777988
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1.
Ouyang B; Knauf JA; Ain K; Nacev B; Fagin JA
Clin Endocrinol (Oxf); 2002 Mar; 56(3):341-50. PubMed ID: 11940046
[TBL] [Abstract][Full Text] [Related]
16. Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival.
Shichiri M; Yoshinaga K; Hisatomi H; Sugihara K; Hirata Y
Cancer Res; 2002 Jan; 62(1):13-7. PubMed ID: 11782350
[TBL] [Abstract][Full Text] [Related]
17. Genetic and transcriptional analysis of spindle checkpoint genes in bone marrow failure patients.
Yamaguchi H; Aridgides LJ; Zeng W; Osgood C; Young NS; Liu JM
Blood Cells Mol Dis; 2003; 30(3):307-11. PubMed ID: 12737950
[TBL] [Abstract][Full Text] [Related]
18. Frequent impairment of the spindle assembly checkpoint in hepatocellular carcinoma.
Saeki A; Tamura S; Ito N; Kiso S; Matsuda Y; Yabuuchi I; Kawata S; Matsuzawa Y
Cancer; 2002 Apr; 94(7):2047-54. PubMed ID: 11932908
[TBL] [Abstract][Full Text] [Related]
19. DNA aneuploidy-specific therapy for head and neck squamous cell carcinoma.
García Martínez J; García-Inclán C; Suárez C; Llorente JL; Hermsen MA
Head Neck; 2015 Jun; 37(6):884-8. PubMed ID: 24623685
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
